5/22/2014 9:49:19 AM
JUPITER, Fla.--(BUSINESS WIRE)--BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTCBB:BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, today announced that it has entered into a two-year collaborative Research Agreement (“Agreement”) with Pfizer Inc. (“Pfizer”) to study human brown adipose tissue and cell lines.
Help employers find you! Check out all the jobs and post your resume.
comments powered by